Frontiers in Immunology

General Commentary

Published on 12 Feb 2025

Commentary: Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of the Meet-Uro 15 study

in Cancer Immunity and Immunotherapy

Martina Catalano
Sara Elena Rebuzzi
Giuseppe Fornarini
Giandomenico Roviello

Frontiers in Immunology

doi 10.3389/fimmu.2025.1555559

1,150 views

Case Report

Published on 12 Feb 2025

A remarkable and durable response to tislelizumab treatment of an anaplastic thyroid carcinoma without targetable genomic alterations: a case report

in Cancer Immunity and Immunotherapy

Jingjing Chai
Jiaqi Lv
Jian Xiong
Xiuwen Chen
Senyuan Luo
Zhiguo Luo
Ming Luo

Frontiers in Immunology

doi 10.3389/fimmu.2025.1544604

3,196 views

Original Research

Published on 12 Feb 2025

Prognostic value of the lactate dehydrogenase to albumin ratio in advanced non-small cell lung cancer patients treated with the first-line PD-1 checkpoint inhibitors combined with chemotherapy

in Cancer Immunity and Immunotherapy

Meifeng Luo
Huiting Wei
Moqin Qiu
Cuiyun Su
Ruiling Ning
Shaozhang Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2025.1473962

3,414 views
6 citations

Editorial

Published on 12 Feb 2025

Editorial: Impact of the innate and adaptive immune system in driving type 1 inflammatory skin disease

in Molecular Innate Immunity

Mark Mellett
Judit Danis
Barbara Meier-Schiesser

Frontiers in Immunology

doi 10.3389/fimmu.2025.1568773

2,693 views
2 citations

Original Research

Published on 12 Feb 2025

Alpha-defensins increase NTHi binding but not engulfment by the macrophages enhancing airway inflammation in Alpha-1 antitrypsin deficiency

in Molecular Innate Immunity

Jungnam Lee
Naweed Mohammad
Kyudong Han
Tammy Flagg-Dowie
Maria Magallon
Mark L. Brantly
Karina A. Serban

Frontiers in Immunology

doi 10.3389/fimmu.2025.1543729

3,130 views
3 citations

Original Research

Published on 12 Feb 2025

Advanced disease and CD8+ TEMRA cells predict severe infections in multiple myeloma

in Cancer Immunity and Immunotherapy

Eva Tranter
David Busch
Clarissa Heck
Igor Wolfgang Blau
Axel Nogai
Phillip Schiele
Christian Meisel
Lars Bullinger
Marco Frentsch
Il-Kang Na

Frontiers in Immunology

doi 10.3389/fimmu.2025.1532645

3,892 views

Original Research

Published on 12 Feb 2025

IFNλ1 is a STING-dependent mediator of DNA damage and induces immune activation in lung cancer

in Cancer Immunity and Immunotherapy

Stine Høvring Godsk
Caroline Maren Stengaard Jensen
Trine Vilsbøll Larsen
Johanne Ahrenfeldt
Kristine Raaby Gammelgaard
Martin Roelsgaard Jakobsen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1525083

5,737 views
2 citations

Original Research

Published on 12 Feb 2025

Associations of prognostic nutritional index with cardiovascular all-cause mortality among CVD patients with diabetes or prediabetes: evidence from the NHANES 2005–2018

in Nutritional Immunology

WenYi Xu
Li Zhang
QianKun Yang
Ying Cao
Rui Rao
Li Lv
Qin Cen
Qiong Wei
LuLing Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1518295

6,749 views
7 citations

Hypothesis and Theory

Published on 12 Feb 2025

Unique gating strategy identifier based on the Prime Population System and Gödel Numbers

in Systems Immunology

Antonio Cosma

Frontiers in Immunology

doi 10.3389/fimmu.2025.1481412

2,038 views

Correction

Published on 12 Feb 2025

Corrigendum: Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs

in Molecular Innate Immunity

Lisa Hurler
Erik J. M. Toonen
Erika Kajdácsi
Bregje van Bree
Ricardo J. M. G. E. Brandwijk
Wieke de Bruin
Paul A. Lyons
Laura Bergamaschi
Cambridge Institute of Therapeutic Immunology Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration
György Sinkovits

Frontiers in Immunology

doi 10.3389/fimmu.2025.1561850

1,512 views

Review

Published on 12 Feb 2025

Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease

in Viral Immunology

Hiam Naiditch
Michael R. Betts
H. Benjamin Larman
Moshe Levi
Avi Z. Rosenberg

Frontiers in Immunology

doi 10.3389/fimmu.2024.1376654

10,428 views
9 citations

Original Research

Published on 12 Feb 2025

Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Loïs Bolko
Céline Anquetil
Alba Llibre
Solène Maillard
Damien Amelin
Karim Dorgham
Vincent Bondet
Océane Landon-Cardinal
Ségolène Toquet
Kuberaka Mariampillai

Frontiers in Immunology

doi 10.3389/fimmu.2025.1529582

4,313 views
4 citations

Review

Published on 12 Feb 2025

A new strategy for the treatment of advanced ovarian cancer: utilizing nanotechnology to regulate the tumor microenvironment

in Cancer Immunity and Immunotherapy

Zixuan Xiong
Yichun Huang
Shulong Cao
Xuqun Huang
Haiyuan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1542326

5,564 views
6 citations

Original Research

Published on 12 Feb 2025

Prognostic value of body adipose tissue parameters in cancer patients treated with immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Yan Li
Yean Yu
Kun Lv
Rongjuan Ge
Xie Xie

Frontiers in Immunology

doi 10.3389/fimmu.2025.1557726

2,015 views
2 citations

Case Report

Published on 12 Feb 2025

Case report: Patients with positive HER-2 amplification locally advanced gastroesophageal junction cancer achieved pathologic complete response with the addition of pembrolizumab to chemotherapy plus trastuzumab as neoadjuvant therapy

in Cancer Immunity and Immunotherapy

Huanhuan Li
Chao Ren
Donghai Cui
Tao Wu
Zhiyong Nie

Frontiers in Immunology

doi 10.3389/fimmu.2025.1555074

3,649 views

Mini Review

Published on 12 Feb 2025

Advancing biliary tract malignancy treatment: emerging frontiers in cell-based therapies

in Cancer Immunity and Immunotherapy

Jianyang Ao
Mingtai Hu
Jinghan Wang
Xiaoqing Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1559465

6,650 views
2 citations

Original Research

Published on 12 Feb 2025

CAV1 promotes epithelial-to-mesenchymal transition (EMT) and chronic renal allograft interstitial fibrosis by activating the ferroptosis pathway

in Alloimmunity and Transplantation

Qianguang Han
Bin Ni
Wei Bao
Junqi Zhang
Ming Zheng
Jinxu Miu
Zijie Wang
Jingwen Yuan
Jun Tao
Zhijian Han

Frontiers in Immunology

doi 10.3389/fimmu.2025.1523855

5,270 views
2 citations

Original Research

Published on 12 Feb 2025

CD21low B cells reveal a unique glycosylation pattern with hypersialylation and hyperfucosylation

in Primary Immunodeficiencies

Peter Tobias Felixberger
Geoffroy Andrieux
Andrea Maul-Pavicic
Sigune Goldacker
Ina Harder
Sylvia Gutenberger
Jonathan J. M. Landry
Vladimir Benes
Till Fabian Jakob
Melanie Boerries

Frontiers in Immunology

doi 10.3389/fimmu.2025.1512279

3,403 views

Review

Published on 12 Feb 2025

Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects

in Cancer Immunity and Immunotherapy

Alberto L. Horenstein
Angelo C. Faini
Fabio Morandi
Erika Ortolan
Paola Storti
Nicola Giuliani
Paul G. Richardson
Fabio Malavasi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1519300

6,290 views
7 citations

Original Research

Published on 12 Feb 2025

NALCN expression is down-regulated and associated with immune infiltration in gastric cancer

in Cancer Immunity and Immunotherapy

Xuewei Li
Na Wu
Chen Wang
Beibei Pei
Xiaoyan Ma
Jun Xie
Wenhui Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1512107

4,654 views
3 citations

Systematic Review

Published on 12 Feb 2025

Effectiveness and safety of PD-1/L1 inhibitors as first-line therapy for patients with advanced or metastatic urothelial carcinoma who are ineligible for platinum-based chemotherapy: a meta-analysis

in Cancer Immunity and Immunotherapy

Weiming Liang
Zhijing Wang
Zhilong Huang
Yanping Huang
Chunyan Li
Yiwen Liang
Miaoyan Huang
Duo Zhang
Chenchen Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1430673

5,144 views
1 citation

Systematic Review

Published on 12 Feb 2025

Efficacy of high-dose steroids versus low-dose steroids in the treatment of immune checkpoint inhibitor-associated myocarditis: a case series and systematic review

in Cancer Immunity and Immunotherapy

Xiuyue Man
Hong Wang
Chen Chen
Xiaofeng Cong
Lemeng Sun
Xueru Sun
Chen Chen
Jing Zhang
Lei Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1455347

5,091 views
9 citations

Original Research

Published on 12 Feb 2025

Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis

in Cancer Immunity and Immunotherapy

Daciana C. Dumut
Marian Hajduch
Amanda M. Zacharias
Qingling Duan
Ivo Frydrych
Zuzana Rozankova
Miroslav Popper
Dusan Garic
Radu Alexandru Paun
Amanda Centorame

Frontiers in Immunology

doi 10.3389/fimmu.2025.1491450

4,314 views
1 citation

Systematic Review

Published on 12 Feb 2025

Comprehensive analysis of publications concerning combinations of immunotherapy and targeted therapies for hepatocellular carcinoma: a bibliometric study

in Cancer Immunity and Immunotherapy

Biling Gan
Lei Wu
Shunan Zhou
Zhihong Chen
Fan Wu
Lianqun Xu
Zhenrong Chen
Honghui Ma
Peijia He
Dan Fang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1476146

5,276 views
2 citations

41,770 articles

articles

Commentary: Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of the Meet-Uro 15 study

A remarkable and durable response to tislelizumab treatment of an anaplastic thyroid carcinoma without targetable genomic alterations: a case report

Prognostic value of the lactate dehydrogenase to albumin ratio in advanced non-small cell lung cancer patients treated with the first-line PD-1 checkpoint inhibitors combined with chemotherapy

Editorial: Impact of the innate and adaptive immune system in driving type 1 inflammatory skin disease

Alpha-defensins increase NTHi binding but not engulfment by the macrophages enhancing airway inflammation in Alpha-1 antitrypsin deficiency

Advanced disease and CD8+ TEMRA cells predict severe infections in multiple myeloma

IFNλ1 is a STING-dependent mediator of DNA damage and induces immune activation in lung cancer

Associations of prognostic nutritional index with cardiovascular all-cause mortality among CVD patients with diabetes or prediabetes: evidence from the NHANES 2005–2018

Unique gating strategy identifier based on the Prime Population System and Gödel Numbers

Corrigendum: Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs

Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease

Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis

A new strategy for the treatment of advanced ovarian cancer: utilizing nanotechnology to regulate the tumor microenvironment

Prognostic value of body adipose tissue parameters in cancer patients treated with immune checkpoint inhibitors

Case report: Patients with positive HER-2 amplification locally advanced gastroesophageal junction cancer achieved pathologic complete response with the addition of pembrolizumab to chemotherapy plus trastuzumab as neoadjuvant therapy

Advancing biliary tract malignancy treatment: emerging frontiers in cell-based therapies

CAV1 promotes epithelial-to-mesenchymal transition (EMT) and chronic renal allograft interstitial fibrosis by activating the ferroptosis pathway

CD21low B cells reveal a unique glycosylation pattern with hypersialylation and hyperfucosylation

Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects

NALCN expression is down-regulated and associated with immune infiltration in gastric cancer

Effectiveness and safety of PD-1/L1 inhibitors as first-line therapy for patients with advanced or metastatic urothelial carcinoma who are ineligible for platinum-based chemotherapy: a meta-analysis

Efficacy of high-dose steroids versus low-dose steroids in the treatment of immune checkpoint inhibitor-associated myocarditis: a case series and systematic review

Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis

Comprehensive analysis of publications concerning combinations of immunotherapy and targeted therapies for hepatocellular carcinoma: a bibliometric study